The Lancet Publishes Systematic Review Examining Innovative Financing Instruments For Global Health From 2002-2015
The Lancet Global Health: Innovative financing instruments for global health 2002-15: a systematic analysis
Rifat Atun, professor and director of the Global Health Systems Cluster at the Harvard T.H. Chan School of Public Health; Sachin Silva, consultant at the WHO and doctoral candidate at the Harvard T.H. Chan School of Public Health; and Felicia M. Knaul, professor in the Department of Public Health Sciences at the Miller School of Medicine and director of the Institute for Advanced Study of the Americas at the University of Miami, conducted a systematic review to examine innovative financing instruments (IFIs) in order to estimate the mobilization of funds for global health from 2002 to 2015. The authors note, “The ten IFIs analyzed collectively accounted for around $8.9 billion (2.3 percent) of the $391.4 billion in DAH generated between 2002 and 2015, and have the potential to attain larger scale. Much of the new funding raised using IFIs were channeled through [Gavi, the Vaccine Alliance], the Global Fund, and UNITAID” (July 2017).